Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 36 | +1 |
| Shares | 8.43M | 7.88M | −549.9K (−6.5%) |
| Value | $52.1M | $34.7M | −$17.4M (−33.3%) |
New holders (5)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jmac Enterprises LLC | 54,538 | $216.0K | 0.05% |
| Ameritas Advisory Services, LLC | 24,219 | $107.0K | 0.00% |
| Citadel Advisors LLC | 10,174 | $45.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,056 | $9.00K | 0.00% |
| Federated Hermes, Inc. | 211 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 409,759 | $2.53M |
| Virtu Financial LLC | 18,610 | $115.0K |
| JPMorgan Chase & Co | 20 | $0 |
| Jacobi Capital Management LLC | 3 | $0 |